NCT00480766View on ClinicalTrials.gov

A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

173

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Osteoporosis

Interventions

DRUG

MK0217/Duration of Treatment : 12 Months

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00480766 - A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED) | Biotech Hunter | Biotech Hunter